Catalyst's New Drug Was Old News, Investors Say
A putative class of Catalyst Pharmaceutical Partners Inc. investors on Thursday accused the company in Florida federal court of inflating its stock price by misrepresenting its orphan drug Firdapse as new,...To view the full article, register now.
Already a subscriber? Click here to view full article